Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia

E. Faughnan, Marie; J. Mager, Johannes; W. Hetts, Steven; A. Palda, Valerie; Lang‐Robertson, Kelly; Buscarini, Elisabetta; Deslandres, Érik; S. Kasthuri, Raj; Lausman, Andrea; M. Poetker, David; Ratjen, Félix; S. Chesnutt, Mark; S. Clancy, Marianne; J. Whitehead, Kevin; Al‐Samkari, Hanny; M. Chakinala, Murali; Conrad, Miles; H. Cortes, Daniel; Crocione, Claudia; M. Darling, Jama; de Gussem, Els; Derksen, Carol; Dupuis‐Girod, Sophie; Foy, Patrick; W. Geisthoff, Urban; R. Gossage, James; M. Hammill, Adrienne; Heimdal, Ketil; Henderson, Katharine; Iyer, Vivek; Drøhse Kjeldsen, Anette; Komiyama, Masaki; Korenblat, Kevin; McDonald, Jamie; McMahon, Jack; P. McWilliams, Justin; E. Meek, Mary; Mei‐Zahav, Meir; E. Olitsky, Scott; Palmer, Sara; Pantalone, Rose; F. Piccirillo, Jay; Plahn, Beth; Porteous, Mary; C. Post, Marco; Radovanovic, Ivan; J. Rochon, Paul; Rodriguez‐Lopez, Josanna; Sabbà, Carlo; M. Serra, Marcelo; L. Shovlin, Claire; L. Sprecher, Dennis; J. White, Andrew; Winship, Ingrid; Zarrabeitia, Roberto

doi:10.7326/m20-1443

Public

Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia

Published in Annals of Internal Medicine • Sep 7, 2020

Authors:

Marie E. Faughnan

Johannes J. Mager

Steven W. Hetts

Abstract

DESCRIPTION: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease with an estimated prevalence of 1 in 5000 that is characterized by the presence of vascular malformations (VMs). These result in chronic bleeding, acute hemorrhage, and complications from shunting through VMs. ...

Subject

Medicine

Telangiectasia

Grading (engineering)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!